Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve

<div>DDA and quantitative protein detection. (a) Identification of DEPs in DOR FF. (b) Venn diagram of the DEPs between the DOR group and the KLP-treated group. (c) Cluster analysis chart of the identified DEPs (higher red and blue intensities indicate a higher degree of upregulation and downregulation, respectively). (d) PCA chart.</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve 

Figure 4 | Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve 